CTRx^®

Focus on what truly matters – providing patients with access to the medicine they need

Drug shortage, waste, and patient access to products are common obstacles in any clinical trial – drugs are expensive and challenging to source, patient enrollment is difficult, and sites are over-burdened. With CTRx^® start your clinical trial faster and eliminate the costs of up-front bulk purchasing, storage, packaging, and labeling, inventory management, and costly drug waste. CTRx^® is the only combination solution on the market that also tailors to additional services that complement your overall trial including packaging and labeling.

Benefits

• Easily integrated with other Myonex services
• Cost savings
• Site and patient-centric
• No waste
• Fast study start-up
• Access to limited distribution specialty medications/hospital line products
• Decentralized Clinical Trials (DCT)/Direct to Patient (DtP) support

Eliminate Bulk Purchases

With CTRx^®, clinical trial managers can remove the guesswork and risk associated with enrollment forecasting and expectations. Minimal lead times for product is managed locally in key markets and waste is minimized through the use of off the shelf supply. Sponsors pay for drug based on local demand, eliminating costly waste and ensuring a more efficient and patient-centric approach.